Tirzepatide Results in Superior Mean Percent Change in Body Weight for Those with Obesity
December 13th 2023In the phase 3 SURMOUNT-4 trial, investigators included individuals with at least 1 weight-related complication, including hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease.
Read More
MAPS PBC Submits NDA to the FDA for MDMA-Assisted Therapy for PTSD
December 12th 2023An FDA approval of 3,4-Methylenedioxy-methamphetamine (MDMA)–assisted therapy would require the Drug Enforcement Administration to reschedule MDMA in acknowledgement of its medical use, making it available for prescription medical use.
Read More
High-Risk Pediatric Patients With Antiphospholipid Syndrome Present Risk of Severe Health Issues
December 11th 2023The results found that 93% of individuals in the high-risk group presented persistently positive antiphospholipid antibodies, compared with 47% of individuals in the lower-risk group.
Read More
Psychedelic-Assisted Therapy: A Novel, Yet Effective Approach to Treating Mental Health Disorders
December 11th 2023By combining the administration of psychedelic compounds with therapeutic support, ketamine-assisted therapy is proving remarkable efficacy in treating mental health conditions.
Read More